fusidic acid has been researched along with lactic acid in 7 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (lactic acid) | Trials (lactic acid) | Recent Studies (post-2010) (lactic acid) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 46,263 | 3,349 | 19,053 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ahiskali, R; Cevher, E; Kan, PL; Mülazimoğlu, L; Orhan, Z; Sağirli, O; Sensoy, D | 1 |
| Burt, HM; Needham, D; Plackett, D; Yang, C | 1 |
| Aloufy, AK; Boraei, NA; El-Halfawy, OM; El-Khordagui, LK; Said, SS | 1 |
| Aloufy, AK; Boraei, NA; El-Gowelli, HM; El-Halfawy, OM; El-Khordagui, LK; Said, SS | 1 |
| Burt, HM; Gilchrist, SE; Letchford, K; Needham, D; Rickard, DL | 1 |
| Bach, H; Burt, HM; Fazli, L; Gilchrist, SE; Lange, D; Letchford, K | 1 |
7 other study(ies) available for fusidic acid and lactic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
Topics: Animals; Calorimetry, Differential Scanning; Chronic Disease; Drug Carriers; Fusidic Acid; Lactic Acid; Male; Methicillin Resistance; Microscopy, Electron, Scanning; Microspheres; Osteogenesis; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Radiography; Rats; Rats, Wistar; Staphylococcus aureus | 2007 |
PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections.
Topics: Anti-Bacterial Agents; Calorimetry, Differential Scanning; Delayed-Action Preparations; Fusidic Acid; Glycolates; Kinetics; Lactic Acid; Microspheres; Particle Size; Phase Transition; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Powder Diffraction; Surface Properties; X-Ray Diffraction | 2009 |
Antimicrobial PLGA ultrafine fibers: interaction with wound bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bandages; Biofilms; Drug Compounding; Drug Delivery Systems; Drug Evaluation, Preclinical; Fusidic Acid; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanofibers; Particle Size; Plankton; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pseudomonas aeruginosa; Staphylococcus aureus; Surface Properties; Wound Healing; Wound Infection | 2011 |
Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; Biofilms; Cellular Microenvironment; Esterases; Female; Fusidic Acid; Lactic Acid; Nanofibers; Particulate Matter; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silicones; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Wound Healing; Wound Infection | 2012 |
Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres.
Topics: Calorimetry, Differential Scanning; Drug Compounding; Fusidic Acid; Lactic Acid; Microscopy, Confocal; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Spectrum Analysis, Raman | 2012 |
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections.
Topics: Animals; Anti-Bacterial Agents; Arthroplasty, Replacement; Bacterial Infections; Drug Delivery Systems; Female; Fusidic Acid; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Rifampin; Staphylococcus epidermidis | 2013 |